Collabrium Japan Acquisition Corporation Announces

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Collabrium Japan Acquisition Corporation Announces Termination and Redemption of Public Shares

LONDON, Feb. 13, 2015 (GLOBE NEWSWIRE) -- Collabrium Japan Acquisition Corporation (the "Company" or "Collabrium") (OTC Pink: JACQF, JACWF, JACNF) announced today that it will redeem all of the outstanding ordinary shares that were issued in its initial public offering (the "Public Shares"), effective as of the close of business on February 24, 2015, because it will not be able to consummate an initial business combination within the time period required by its memorandum and articles of association, as amended and restated (the "Charter").

Pursuant to the Charter, the Company has until February 24, 2015 to consummate an initial business combination. The Company's failure to consummate a business combination by such date will trigger the automatic redemption of the Public Shares. The Charter requires that the Company redeem the Public Shares, no more than ten business days after such date, for a per-share redemption price, payable in cash, equal to the aggregate amount on deposit in the Company's trust account divided by the number of outstanding Public Shares. The per-share redemption price will be $10.52619. The Charter further requires that, as promptly as practicable, the Company cease all operations except for the purpose of completing such redemption and any winding up of the Company's affairs.

The Public Shares will cease trading as of the open of business on February 20, 2015, in order to allow time for the settlement of trades. As of the close of business on February 24, 2015, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount. The redemption amount will be payable to the holders of record of the Public Shares (including the Public Shares included in the Company's units) upon presentation of their stock or unit certificates or other delivery of their shares or units. Beneficial owners of Public Shares held in "street name," however, will not need to take any action in order to receive the redemption amount.

There will be no redemption rights with respect to the Company's warrants, which will expire worthless. The Company's initial shareholders have waived their redemption rights with respect to the outstanding ordinary shares issued prior to the Company's initial public offering.

In connection with the previously disclosed delisting of the Company's securities from The Nasdaq Stock Market ("Nasdaq"), the Company expects that Nasdaq will file a Form 25 with the Securities and Exchange Commission to terminate the Company's registration under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Upon effectiveness of the delisting, the Company expects to file a Form 15 with the Securities and Exchange Commission for the purpose of completing the suspension of its reporting obligations under the Exchange Act.

About Collabrium

Collabrium Japan Acquisition Corporation is a blank check company that had been organized for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchasing all or substantially all of the assets of, or any other similar business combination with, one or more businesses or entities.

Forward-Looking Statements

In addition to historical information, this release may contain a number of "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to outlooks or expectations for earnings, revenues, expenses or other future financial or business performance, strategies or expectations, or the impact of legal or regulatory matters on business, results of operations or financial condition. When used in this release, the words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "potential" and "should," as they relate to the Company are intended to identify these forward-looking statements. All statements by the Company regarding the possible or assumed future results of its business, financial condition, liquidity, results of operations, plans and objectives and similar matters are forward-looking statements. These forward-looking statements are based on information available to Collabrium as of the date hereof and involve a number of risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing Collabrium's views as of any subsequent date. These forward-looking statements involve a number of known and unknown risks and uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements. Except as may be required pursuant to applicable securities laws, Collabrium undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date hereof, whether as a result of new information, future events or otherwise.

Koji Fusa Collabrium Japan Acquisition Corporation 44-20-7222-9637

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 55

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 53

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 55

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 15

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 21

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 45

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
Tiny Fish Revolutionizes Vertebrate Gene Studies

Updated Category News Views 41

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 85

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading

Top 5 Most Recently Viewed Articles

ASUR 4Q25 Earnings: Traffic Boost in Colombia, Mixed Signals

Updated Category News Views 165

Passenger Trends: A Bit of a Mixed Bag Traffic numbers can sometimes tell the real story, and for ASUR, it’s like reading a novel with plot twists. Colombia’s passenger traffic jumped 5.7%, fueled by robust international and domestic movements. Meanwhile, back in Puerto Rico? Things were not as rosy with a 3.1% drop due to lackluster domestic traffic. Mexico showed a...

Continue Reading
CVS Health's Unexpected Earnings Miss Sparks Analyst Optimism

Updated Category News Views 169

CVS Health Faces Challenges While Analysts Stay Positive Shares of CVS Health Corp (NYSE: CVS) have recently experienced a decline following the company’s preannouncement of a substantial earnings miss for the third quarter. This news comes during an exciting earnings season, generating considerable discussion among analysts and investors alike. Analyst Insights on CVS...

Continue Reading
Intercontinental Exchange Inc: Current Market Dynamics and Insights

Updated Category News Views 128

Understanding Intercontinental Exchange Inc's Market Position Intercontinental Exchange Inc (NYSE: ICE) has recently experienced a notable increase in short interest, which has risen by 8.59% since the last report. Currently, there are approximately 7.83 million shares that have been sold short, representing 1.39% of the total shares available for trading. Based on recent...

Continue Reading
Jason Passwaters: A Visionary Leader in Cybersecurity Innovation

Updated Category News Views 465

Jason Passwaters Receives Honorable Recognition Jason Passwaters, the dynamic CEO of Intel 471, has recently been celebrated for his significant contributions to the business world. His inclusion in the renowned Dallas 500 list acknowledges him as a pivotal figure among influential business leaders in the area. Passwaters’ Journey to Success With a strong foundation in...

Continue Reading
Investigation Launched into Greenwich LifeSciences, Inc.

Updated Category News Views 196

Investigation into Corporate Actions of Greenwich LifeSciences Greenwich LifeSciences, Inc. (NASDAQ: GLSI) finds itself under scrutiny as Purcell & Lefkowitz LLP initiates an investigation concerning potential breaches of fiduciary duties by the company’s directors. This investigation aims to address recent corporate actions that may not have aligned with the best...

Continue Reading